Abstract
Over the last two decades, our experience with transcatheter pulmonary valve replacement (TPVR) has grown significantly and has become an effective and reliable way of treating pulmonary valve regurgitation, right ventricular outflow (RVOT) obstruction, and dysfunctional bioprosthetic valves and conduits. With the introduction of self-expanding valves and prestents, dilated native RVOT can be addressed with transcatheter approach. In this article, we review the current practices, technical challenges, and outcomes of TPVR.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have